---
title: Pandemic Preparedness
---

[Skip to content](https://info.interceptbloodsystem.com/pandemic-preparedness#main-content)

[![cerus_large_2x](https://info.interceptbloodsystem.com/hubfs/Logo/cerus_large_2x.png)](https://interceptbloodsystem.com/en)

- [About](https://interceptbloodsystem.com/en/about)
- [Insights](https://insights.interceptbloodsystem.com)
- [Cerus Campus](https://info.interceptbloodsystem.com/en/cerus-campus)
- [Resources](https://interceptbloodsystem.com/en/resources)
- [Contact](https://interceptbloodsystem.com/en/contact)
- [Ask an expert](https://interceptbloodsystem.com/en/ask-expert)

## Pandemic Preparedness

[Subscribe to our newsletter](https://interceptbloodsystem.com/en/newsletter)

## Want to stay updated on the latest pathogen inactivation news? You can receive our highlights by subscribing to our newsletter.

#### ![ThumbnailKalusPhoto](https://info.interceptbloodsystem.com/hs-fs/hubfs/ThumbnailKalusPhoto.png?width=651&name=ThumbnailKalusPhoto.png)Plasma & Platelets

## How can we guarantee the supply of blood products to patients? Especially with short-life platelet concentrates, even in times of epidemics?

### Priv-Doz. Dr. med. Ulrich Kalus Charité Berlin, Germany 

### [![EN](https://no-cache.hubspot.com/cta/default/2866022/fb9304ab-cee7-4332-af7e-fc384d958a4e.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/fb9304ab-cee7-4332-af7e-fc384d958a4e)   [![DE](https://no-cache.hubspot.com/cta/default/2866022/5dc11382-6eb2-46cf-9981-f5fea1d1882c.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/5dc11382-6eb2-46cf-9981-f5fea1d1882c)

#### ![ThumbnailHindawiPhoto](https://info.interceptbloodsystem.com/hs-fs/hubfs/ThumbnailHindawiPhoto.png?width=442&name=ThumbnailHindawiPhoto.png)

Platelets & Plasma

## Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

### Prof. Salwa Ibrahim Hindawi King Abdulaziz University Jeddah, Saudi Arabia

### [![EN](https://no-cache.hubspot.com/cta/default/2866022/d2e54418-3e57-4c13-9fc4-b2f528ba1916.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/d2e54418-3e57-4c13-9fc4-b2f528ba1916) [![DE](https://no-cache.hubspot.com/cta/default/2866022/7a03f4ed-7c35-4a62-ad47-18bcecf177c6.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/7a03f4ed-7c35-4a62-ad47-18bcecf177c6)   [![ES](https://no-cache.hubspot.com/cta/default/2866022/f3e12d87-aec6-4447-9190-ce530ca055c9.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/f3e12d87-aec6-4447-9190-ce530ca055c9)   [![IT](https://no-cache.hubspot.com/cta/default/2866022/3a1f940c-61d8-4095-a96c-9d505a96e52d.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/3a1f940c-61d8-4095-a96c-9d505a96e52d)  

#### ![ThumbnailBareaPhoto](https://info.interceptbloodsystem.com/hs-fs/hubfs/ThumbnailBareaPhoto.png?width=442&name=ThumbnailBareaPhoto.png)**Platelets & Plasma**

## COVID-19: Lessons learned to safeguard the continuity of blood supply in the Madrid region

### Dr. Luisa Maria Barea Garcia, MD Centro de Transfusión de la Comunidad de Madrid Madrid, Spain

### [![EN](https://no-cache.hubspot.com/cta/default/2866022/d87707a9-2b21-47e7-84e5-9eaa1cccc537.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/d87707a9-2b21-47e7-84e5-9eaa1cccc537) [![DE](https://no-cache.hubspot.com/cta/default/2866022/ff4073a3-637b-4031-9746-b190ad1219d0.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/ff4073a3-637b-4031-9746-b190ad1219d0)   [![ES](https://no-cache.hubspot.com/cta/default/2866022/1eedeba4-4493-4d45-aecb-838dfe0ee4ec.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/1eedeba4-4493-4d45-aecb-838dfe0ee4ec)   [![IT](https://no-cache.hubspot.com/cta/default/2866022/dc8e7822-5b28-448d-92b0-5a10284acfeb.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/dc8e7822-5b28-448d-92b0-5a10284acfeb)   

#### ![ThumbnailStramer](https://info.interceptbloodsystem.com/hs-fs/hubfs/ThumbnailStramer.png?width=650&name=ThumbnailStramer.png)Platelets & Plasma

## Vector-borne diseases in the Americas and Europe - NAT vs PI

### Dr. Susan Stramer, PhD American Red Cross Gaithersburg, Maryland, USA

### [![EN](https://no-cache.hubspot.com/cta/default/2866022/80d5f29c-959c-4c1e-ab2e-0548f9ff367f.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/80d5f29c-959c-4c1e-ab2e-0548f9ff367f)

#### ![ThumbnailHervig](https://info.interceptbloodsystem.com/hs-fs/hubfs/ThumbnailHervig.png?width=442&name=ThumbnailHervig.png)

Plasma & Platelets

## Evolution of the level of blood safety and impact on patient safety: a historic perspective

### Dr. Tor Hervig Haugesund Hospital / University of Bergen Bergen, Norway

### [![EN](https://no-cache.hubspot.com/cta/default/2866022/8be3df24-10c8-4dba-b597-6642f4f2c9b0.png)](https://cta-redirect.hubspot.com/cta/redirect/2866022/8be3df24-10c8-4dba-b597-6642f4f2c9b0)   

[Back](https://info.interceptbloodsystem.com/cerus_campus?hsLang=de#Content)

![cerus_large_2x](https://info.interceptbloodsystem.com/hubfs/Logo/cerus_large_2x.png)

- [Legal Info](https://interceptbloodsystem.com/en/legal-info)
- [Privacy Policy](https://interceptbloodsystem.com/en/privacy-policy)
- [Cookies](https://interceptbloodsystem.com/en/cookie-policy-and-tracking-opt-out-guide)

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located.  
Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions.

Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.

© 2023 Cerus Corporation. All Rights Reserved. MKT-EN 000157, v43.0